Stuart Lutzker
Net worth: 5 M $ as of 30/06/2026
Net worth: 5 M $ as of 30/06/2026
Stuart Lutzker is the founder of Arrivent BioPharma, Inc., founded in 2021, holding the titles of Director and President-Research & Development since 2022.
Former job includes VP, Head-Oncology & Early Clinical Development at Genentech, Inc. from 2004 to 2021.
Education includes undergraduate studies at The Trustees of Columbia University in The City of New York and a doctorate from Columbia University College of Physicians & Surgeons.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 21/04/2026 | 1,47,744 ( 0.32% ) | 5 M $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| ARRIVENT BIOPHARMA, INC. | Founder | 14/04/2021 |
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/03/2021 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University College of Physicians & Surgeons
Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arrivent BioPharma, Inc.
Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
Select your edition
All financial news and data tailored to specific country editions